Phosphodiesterase 3 Inhibitor [EPC]: Side Effects & Safety Data for 3 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Phosphodiesterase 3 Inhibitor [EPC] includes 3 drugs with a combined 2,735 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
3
Drugs in Class
2,735
Combined Reports
All Phosphodiesterase 3 Inhibitor [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| CILOSTAZOL | Cilostazol | 1,475 | 258 | 753 | 17.5% |
| MILRINONE | Milrinone Lactate in Dextrose | 850 | 171 | 374 | 20.1% |
| ENSIFENTRINE | Ohtuvayre | 410 | 2 | 77 | 0.5% |
Common Side Effects in Phosphodiesterase 3 Inhibitor [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Drug ineffective | 425 | 58 |
| Off label use | 140 | 17 |
| Death | 127 | 127 |
| Dyspnoea | 121 | 2 |
| Hypotension | 97 | 30 |
| Condition aggravated | 76 | 13 |
| Diarrhoea | 76 | 12 |
| Headache | 71 | 5 |
| Dizziness | 70 | 4 |
| Atrial fibrillation | 60 | 7 |